CD34 and type 2 diabetes mellitus: Consistently,Spinetti et al. [30], [31] revealed the increased FOXO3a nuclear localization in CD34+ bone marrow progenitor cells isolated from type-2 diabetes mellitus patients, which was associated with upregulation of FOXO3a targets, p21 and p27kip1.